Ulrike Heberling

635 total citations
19 papers, 409 citations indexed

About

Ulrike Heberling is a scholar working on Surgery, Urology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ulrike Heberling has authored 19 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 9 papers in Urology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ulrike Heberling's work include Bladder and Urothelial Cancer Treatments (14 papers), Urinary and Genital Oncology Studies (10 papers) and Urological Disorders and Treatments (9 papers). Ulrike Heberling is often cited by papers focused on Bladder and Urothelial Cancer Treatments (14 papers), Urinary and Genital Oncology Studies (10 papers) and Urological Disorders and Treatments (9 papers). Ulrike Heberling collaborates with scholars based in Germany. Ulrike Heberling's co-authors include Manfred P. Wirth, Vladimír Novotný, Oliver W. Hakenberg, Sven Oehlschlaeger, R. J. Litz, D. Wießner, Michael Froehner, Rainer Koch, Matthias Hübler and Susanne Fuessel and has published in prestigious journals such as International Journal of Molecular Sciences, European Urology and Urology.

In The Last Decade

Ulrike Heberling

19 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulrike Heberling Germany 10 338 165 70 51 37 19 409
Lara Franziska Stolzenbach Germany 13 242 0.7× 61 0.4× 179 2.6× 91 1.8× 39 1.1× 35 391
Hyeong Dong Yuk South Korea 12 176 0.5× 45 0.3× 126 1.8× 97 1.9× 67 1.8× 52 349
Atiqullah Aziz Germany 15 382 1.1× 132 0.8× 116 1.7× 130 2.5× 51 1.4× 30 474
Sunai Leewansangtong Thailand 9 165 0.5× 96 0.6× 173 2.5× 37 0.7× 31 0.8× 44 329
Andrew Kennedy‐Smith New Zealand 8 242 0.7× 77 0.5× 51 0.7× 84 1.6× 55 1.5× 10 308
Francisco Gelpi‐Hammerschmidt United States 9 164 0.5× 44 0.3× 150 2.1× 55 1.1× 32 0.9× 17 286
N. Bissada United States 8 85 0.3× 52 0.3× 125 1.8× 45 0.9× 79 2.1× 27 299
Yosuke Hirasawa Japan 12 144 0.4× 100 0.6× 160 2.3× 107 2.1× 27 0.7× 30 357
Bogomir Milojević Serbia 12 269 0.8× 58 0.4× 80 1.1× 53 1.0× 71 1.9× 41 342
Akinobu Suga Japan 9 151 0.4× 37 0.2× 50 0.7× 51 1.0× 20 0.5× 28 254

Countries citing papers authored by Ulrike Heberling

Since Specialization
Citations

This map shows the geographic impact of Ulrike Heberling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Heberling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Heberling more than expected).

Fields of papers citing papers by Ulrike Heberling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrike Heberling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Heberling. The network helps show where Ulrike Heberling may publish in the future.

Co-authorship network of co-authors of Ulrike Heberling

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrike Heberling. A scholar is included among the top collaborators of Ulrike Heberling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrike Heberling. Ulrike Heberling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Froehner, Michael, Rainer Koch, Ulrike Heberling, et al.. (2020). Validation of a Questionnaire-Suitable Comorbidity Index in Patients Undergoing Radical Cystectomy. Urologia Internationalis. 104(7-8). 567–572. 6 indexed citations
2.
Erdmann, Kati, Karsten Salomo, Anna Klimová, et al.. (2020). Urinary MicroRNAs as Potential Markers for Non-Invasive Diagnosis of Bladder Cancer. International Journal of Molecular Sciences. 21(11). 3814–3814. 20 indexed citations
3.
Froehner, Michael, Rainer Koch, Matthias Hübler, et al.. (2019). Socioeconomic Status-Related Parameters as Predictors of Competing (Non-Bladder Cancer) Mortality after Radical Cystectomy. Urologia Internationalis. 104(1-2). 62–69. 3 indexed citations
4.
Froehner, Michael, Rainer Koch, Ulrike Heberling, et al.. (2019). Long-Term Mortality in Patients with Positive Lymph Nodes at the Time of Radical Prostatectomy. Urologia Internationalis. 103(4). 427–432. 6 indexed citations
5.
Froehner, Michael, Rainer Koch, Ulrike Heberling, et al.. (2019). Which comorbidity classification is best suited to identify patients at risk for 90-day and long-term non-bladder cancer mortality after radical cystectomy?. World Journal of Urology. 38(3). 695–702. 4 indexed citations
6.
Froehner, Michael, Rainer Koch, Matthias Hübler, et al.. (2018). Predicting 90-day and long-term mortality in octogenarians undergoing radical cystectomy. BMC Urology. 18(1). 91–91. 13 indexed citations
7.
Heberling, Ulrike, Rainer Koch, Matthias Hübler, et al.. (2018). Gender and Mortality after Radical Cystectomy: Competing Risk Analysis. Urologia Internationalis. 101(3). 293–299. 6 indexed citations
8.
Stasik, Sebastian, Karsten Salomo, Ulrike Heberling, et al.. (2018). Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancer. Clinical Biochemistry. 64. 60–63. 39 indexed citations
9.
Salomo, Karsten, Alexander Herr, Werner Brabetz, et al.. (2017). Urinary transcript quantitation of CK20 and IGF2 for the non-invasive bladder cancer detection. Journal of Cancer Research and Clinical Oncology. 143(9). 1757–1769. 9 indexed citations
10.
11.
Van, Dana Vu, Ulrike Heberling, Manfred P. Wirth, & Susanne Fuessel. (2016). Validation of the diagnostic utility of urinary midkine for the detection of bladder cancer. Oncology Letters. 12(5). 3143–3152. 9 indexed citations
12.
Froehner, Michael, Rainer Koch, Ulrike Heberling, et al.. (2016). An easily applicable single condition–based mortality index for patients undergoing radical prostatectomy or radical cystectomy. Urologic Oncology Seminars and Original Investigations. 35(1). 32.e17–32.e23. 12 indexed citations
13.
Froehner, Michael, Ulrike Heberling, Stefan Zastrow, Marieta Toma, & Manfred P. Wirth. (2016). Growth of a Level III Vena Cava Tumor Thrombus Within 1 Month. Urology. 90. e1–e2. 14 indexed citations
14.
Novotný, Vladimír, Michael Froehner, Rainer Koch, et al.. (2015). Age, American Society of Anesthesiologists physical status classification and Charlson score are independent predictors of 90-day mortality after radical cystectomy. World Journal of Urology. 34(8). 1123–1129. 18 indexed citations
15.
Froehner, Michael, Rainer Koch, Ulrike Heberling, et al.. (2015). Decreased Overall and Bladder Cancer–Specific Mortality with Adjuvant Chemotherapy After Radical Cystectomy: Multivariable Competing Risk Analysis. European Urology. 69(6). 984–987. 25 indexed citations
16.
Froehner, Michael, Rainer Koch, Vladimír Novotný, et al.. (2015). Lee mortality index as comorbidity measure in patients undergoing radical cystectomy. SpringerPlus. 4(1). 55–55. 2 indexed citations
17.
Heberling, Ulrike, et al.. (2014). Superglue in the Urethra: Surgical Treatment. Urologia Internationalis. 96(1). 119–121. 3 indexed citations
18.
Grimm, Marc‐Oliver, et al.. (2007). Radikale Zystektomie und Harnableitung beim Harnblasenkarzinom. Der Onkologe. 13(12). 1089–1095. 1 indexed citations
19.
Novotný, Vladimír, Oliver W. Hakenberg, D. Wießner, et al.. (2006). Perioperative Complications of Radical Cystectomy in a Contemporary Series. European Urology. 51(2). 397–402. 207 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lara Franziska Stolzenbach Breakdown of academic impact, for papers by Hyeong Dong Yuk Breakdown of academic impact, for papers by Atiqullah Aziz Breakdown of academic impact, for papers by Sunai Leewansangtong Breakdown of academic impact, for papers by Andrew Kennedy‐Smith Breakdown of academic impact, for papers by Francisco Gelpi‐Hammerschmidt Breakdown of academic impact, for papers by N. Bissada Breakdown of academic impact, for papers by Yosuke Hirasawa Breakdown of academic impact, for papers by Bogomir Milojević Breakdown of academic impact, for papers by Akinobu Suga
Rankless by CCL
2026